Submitting OIG:
Date Issued:
Wednesday, November 8, 2023
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-06-22-01002
Component, if applicable:
Food and Drug Administration
Food and Drug Administration
Location(s):
MD,
United StatesType of Report:
Audit
Questioned Costs:
$0
Funds for Better Use:
$0
Number of Recommendations:
2
Report updated under NDAA 5274:
No
View Document:
Attachment | Size |
---|---|
62201002.pdf | 2.57 MB |